About the Company
We do not have any company description for Progyny, Inc. at the moment.
Sector
Industrial Applications and Services
Industry
Services-Misc Health & Allied Services, NEC
Employees
441
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $PGNY News
Insider Sell: President Michael Sturmer Sells Shares of Progyny Inc (PGNY)
Michael Sturmer, President at Progyny Inc (NASDAQ:PGNY), sold 6,395 shares of the company on April 1, 2024, according to a ...
Progyny and Fertility Matters Canada Recognize Canadian Fertility Awareness Week to Advocate for Expanded Access to Family Building Care
In 2007, FMC launched Canadian Infertility Awareness Week (CIAW) to raise awareness and hope in the fertility community. In 2023, CIAW became Canadian Fertility Awareness Week (CFAW), a more inclusive ...
Progyny (NASDAQ: PGNY)
Progyny, Inc. is a fertility benefits management company. It provides fertility solutions to employers, managing IUI, in vitro fertilization (IVF), egg freezing, and other fertility treatments.
Progyny, Inc. Announces Fourth Quarter 2023 Results
Progyny, Inc. (Nasdaq: PGNY) (“Progyny” or the “Company”), a transformative fertility, family building and women's health benefits solution, today announced its financial results for the ...
Progyny, Inc. to Present at KeyBanc Life Sciences & MedTech Investor Forum
NEW YORK, March 18, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, today announced that Pete ...
Progyny Inc.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Progyny executive chairman sells $37,522 in stock
In a recent transaction, David J. Schlanger, the Executive Chairman of Progyny, Inc. (NASDAQ:PGNY), sold shares of the company's common stock, according to the latest SEC filings. Schlanger sold ...
Progyny CFO sells over $419k in company stock
Mark S. Livingston, the Chief Financial Officer of Progyny, Inc. (NASDAQ:PGNY), has recently engaged in significant trading activity involving the company's stock, according to the latest filings.
Executive Chairman David Schlanger Sells 71,272 Shares of Progyny Inc (PGNY)
Executive Chairman David Schlanger of Progyny Inc (NASDAQ:PGNY) has sold 71,272 shares of the company on March 27, 2024, ...
Progyny, Inc. to Present at KeyBanc Life Sciences & MedTech Investor Forum
NEW YORK, March 18, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, today announced that Pete Anevski ...
Progyny executive chairman sells $37,522 in stock
In a recent transaction, David J. Schlanger, the Executive Chairman of Progyny, Inc. (NASDAQ:PGNY), sold shares of the company's common stock, according to the latest SEC filings. Schlanger sold 1,000 ...
Loading the latest forecasts...